Getting serious about the challenge of regulating germline gene therapy

• Published in: PLoS biology Vol. 17; no. 4; p. e3000223
• Main Author: Caplan, Arthur
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 30.04.2019; Public Library of Science (PLoS)
• Subjects: Bans; Bioethics; China; Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR; Deoxyribonucleic acid; DNA; Editing; Embryos; Ethical standards; Ethics; Experiments; Gene Editing - ethics; Gene therapy; Genetic engineering; Genetic Therapy - ethics; Genetic Therapy - legislation & jurisprudence; Genomes; Germ Cells; Germ-Line Mutation - ethics; Germ-Line Mutation - genetics; He Jiankui; Human subjects; Humans; Innovations; Medical research; Morals; Press conferences; Proteins; Science; Scientists; Trust; China; New York; United States > US

The announcement of He Jiankui's germline editing of human embryos has been followed by a torrent of almost universal criticism of the claim on scientific and ethical grounds. That criticism is warranted. There is little room for anything other than vociferous condemnation of He's announce...